meta
|
evidence
COVID-19
Living systematic review and meta-analysis
adjuvant therapies
anti-inflammatoty and immuno-therapy
antiandrogenic
antiviral and associated therapy
Amantadine
ASC09/ritonavir
azithromycin
azvudine
baloxavir marboxil
bromhexine
carrimycin
chloroquine and derivatives
chloroquine
hydroxychloroquine
zinc plus hydroxychloroquine
danoprevir / ritonavir
darunavir cobicistat
darunavir/cobicistat plus chloroquine
doxycycline
Emtricitabine/tenofovir plus colchicine plus rosuvastatin
Ensitrelvir (XOCOVA)
favipiravir
favipiravir plus interferon
fluvoxamine
hydroxychloroquine plus macrolides
azithromycin plus hydroxychloroquine
Interferon plus lopinavir/ritonavir
ivermectin
ivermectin plus doxycycline
leronlimab
lopinavir / ritonavir plus ribavirin
lopinavir/ritonavir
lopinavir/ritonavir plus chloroquine
Lopinavir/ritonavir plus hydroxychloroquine
lopinavir/ritonavir plus interferon ß-1a
lopinavir/ritonavir, ribavirin and interferon beta-1b
molnupiravir
niclosamide
nirmatrelvir / ritonavir (Paxlovid)
nitazoxanide
opaganib
oseltamivir
oseltamivir plus chloroquin
remdesivir
ribavirin
ritonavir
sofosbuvir
sofosbuvir and daclatasvir
sofosbuvir and ledipasvir
tenofovir/emtricitabine
tenofovir/emtricitabine plus hydroxychloroquine
tranexamic acid
tranilast
triazavirin
umifenovir (arbidol)
zinc
control
Drugs for acid related disorders
miscellaneous
Oral antidiabetic drugs
Renin-angiotensin-system-acting agents
vaccines
Vitamins
COVID 19 hospitalized
COVID 19 all comers
COVID-19 mild to moderate
COVID-19 severe or critically
COVID 19 outpatients
COVID-19 (hospitalized or not)
COVID-19 prophylaxis (children)
COVID-19 prophylaxis (excluding children)
infections other than COVID-19
Long COVID-19
preventing respiratory virus transmission
secondary prevention
Meta-analysis results for all treatments
Treatment relative effect with 95% CI; and degree of certainty (adaptated from GRADE).
method
Treament
Trials
Summary
Endpoints
core analysis (OBS if no RCT)
RCTs only
all (RCT+OBS)
Demonstrated or suggested benefit
Inconclusive results
Uncertain results
Safety results
Amantadine
0
-
-
-
-
ASC09/ritonavir
0
-
-
-
-
azithromycin
0
-
-
-
-
azvudine
0
-
-
-
-
baloxavir marboxil
0
-
-
-
-
bromhexine
0
-
-
-
-
carrimycin
0
-
-
-
-
chloroquine and derivatives
0
-
-
-
-
danoprevir / ritonavir
0
-
-
-
-
darunavir cobicistat
0
-
-
-
-
doxycycline
0
-
-
-
-
Emtricitabine/tenofovir plus colchicine plus rosuvastatin
0
-
-
-
-
Ensitrelvir (XOCOVA)
0
-
-
-
-
favipiravir
0
-
-
-
-
favipiravir plus interferon
0
-
-
-
-
fluvoxamine
0
-
-
-
-
hydroxychloroquine plus macrolides
0
-
-
-
-
Interferon plus lopinavir/ritonavir
0
-
-
-
-
ivermectin
0
-
-
-
-
leronlimab
0
-
-
-
-
lopinavir / ritonavir plus ribavirin
0
-
-
-
-
lopinavir/ritonavir
0
-
-
-
-
lopinavir/ritonavir plus chloroquine
0
-
-
-
-
Lopinavir/ritonavir plus hydroxychloroquine
0
-
-
-
-
lopinavir/ritonavir plus interferon ß-1a
0
-
-
-
-
lopinavir/ritonavir, ribavirin and interferon beta-1b
0
-
-
-
-
molnupiravir
0
-
-
-
-
niclosamide
0
-
-
-
-
nirmatrelvir / ritonavir (Paxlovid)
0
-
-
-
-
nitazoxanide
0
-
-
-
-
opaganib
0
-
-
-
-
oseltamivir
0
-
-
-
-
oseltamivir plus chloroquin
0
-
-
-
-
remdesivir
0
-
-
-
-
ribavirin
0
-
-
-
-
ritonavir
0
-
-
-
-
sofosbuvir
0
-
-
-
-
sofosbuvir and daclatasvir
0
-
-
-
-
sofosbuvir and ledipasvir
0
-
-
-
-
tenofovir/emtricitabine
0
-
-
-
-
tenofovir/emtricitabine plus hydroxychloroquine
0
-
-
-
-
tranexamic acid
0
-
-
-
-
tranilast
0
-
-
-
-
triazavirin
0
-
-
-
-
umifenovir (arbidol)
0
-
-
-
-
zinc
0
-
-
-
-